Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Ferreira

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
ERJ Open Research|May 20, 2025
A comprehensive evaluation of murine and human <i>ex vivo</i> cultured alveolar macrophagesCamille David, Deborah Brea, Charles Verney, et al.
Respiratory Medicine|September 24, 2020
Efficacy and safety of rituximab in patients with chronic hypersensitivity pneumonitis (cHP): A retrospective, multicentric, observational studyMarion Ferreira, Raphaël Borie, Bruno Crestani, et al.
The Lancet. Respiratory Medicine|July 11, 2020
Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort studyCharles-Hugo Marquette, Jacques Boutros, Jonathan Benzaquen, et al.
Respiratory Medicine and Research|December 18, 2024
Evaluation of efficacy and safety of rituximab in patients with progressive interstitial lung disease (ILD) with inflammatory component (EvER-ILD2): A multicentre double-blind placebo-controlled randomized trialMarion Ferreira, Theodora Bejan-Angoulvant, Sylvain Marchand-Adam, et al.
The Journal of Experimental Medicine|September 4, 2020
Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patientsYouenn Jouan, Antoine Guillon, Loïc Gonzalez, et al.
Therapeutic Advances in Medical Oncology|August 5, 2021
Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03)Francesco Grossi, Piotr Jaśkiewicz, Marion Ferreira, et al.
Lung Cancer (Amsterdam, Netherlands)|October 15, 2023
Characterization of 164 patients with NRAS mutated non-small cell lung cancer (NSCLC)Agathe Dehem, Julien Mazieres, Ali Chour, et al.
Lung Cancer (Amsterdam, Netherlands)|September 15, 2024
Capmatinib efficacy for METex14 non-small cell lung cancer patients: Results of the IFCT-2104 CAPMATU studyMarion Ferreira, Aurélie Swalduz, Laurent Greillier, et al.
BMC Pulmonary Medicine|November 18, 2022
Tracheobronchopathia osteochondroplastica: clinical, bronchoscopic, and comorbid features in a case seriesAntoine Dumazet, Claire Launois, Francois Lebargy, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
ERJ Open Research|May 20, 2025
A comprehensive evaluation of murine and human <i>ex vivo</i> cultured alveolar macrophagesCamille David, Deborah Brea, Charles Verney, et al.
Respiratory Medicine|September 24, 2020
Efficacy and safety of rituximab in patients with chronic hypersensitivity pneumonitis (cHP): A retrospective, multicentric, observational studyMarion Ferreira, Raphaël Borie, Bruno Crestani, et al.
The Lancet. Respiratory Medicine|July 11, 2020
Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort studyCharles-Hugo Marquette, Jacques Boutros, Jonathan Benzaquen, et al.
Respiratory Medicine and Research|December 18, 2024
Evaluation of efficacy and safety of rituximab in patients with progressive interstitial lung disease (ILD) with inflammatory component (EvER-ILD2): A multicentre double-blind placebo-controlled randomized trialMarion Ferreira, Theodora Bejan-Angoulvant, Sylvain Marchand-Adam, et al.
The Journal of Experimental Medicine|September 4, 2020
Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patientsYouenn Jouan, Antoine Guillon, Loïc Gonzalez, et al.
Therapeutic Advances in Medical Oncology|August 5, 2021
Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03)Francesco Grossi, Piotr Jaśkiewicz, Marion Ferreira, et al.
Lung Cancer (Amsterdam, Netherlands)|October 15, 2023
Characterization of 164 patients with NRAS mutated non-small cell lung cancer (NSCLC)Agathe Dehem, Julien Mazieres, Ali Chour, et al.
Lung Cancer (Amsterdam, Netherlands)|September 15, 2024
Capmatinib efficacy for METex14 non-small cell lung cancer patients: Results of the IFCT-2104 CAPMATU studyMarion Ferreira, Aurélie Swalduz, Laurent Greillier, et al.
BMC Pulmonary Medicine|November 18, 2022
Tracheobronchopathia osteochondroplastica: clinical, bronchoscopic, and comorbid features in a case seriesAntoine Dumazet, Claire Launois, Francois Lebargy, et al.
Pageof 2